DGNSS Cooperative Positioning in Mobile Smart Devices: A Proof of Concept

Global Navigation Satellite System (GNSS) constitutes the foremost provider for geo-localization in a growing number of consumer-grade applications and services supporting urban mobility. Therefore, low-cost and ultra-low-cost, embedded GNSS receivers have become ubiquitous in mobile devices such as smartphones and consumer electronics to a large extent. However, limited sky visibility and multipath scattering induced in urban areas hinder positioning and navigation capabilities, thus threatening the quality of position estimates. This work leverages the availability of raw GNSS measurements in ultralow-cost smartphone chipsets and the ubiquitous connectivity provided by modern, low-latency network infrastructures to enable a Cooperative Positioning (CP) framework. A Proof Of Concept is presented that aims at demonstrating the feasibility of a GNSS-only CP among networked smartphones embedding ultra-low-cost GNSS receivers. The test campaign presented in this study assessed the feasibility of a client-server approach over 4G/LTE network connectivity. Results demonstrated an overall service availability above 80%, and an average accuracy improvement over the 40% w.r.t. to the GNSS standalone solution

Cooperative Localization Enhancement through GNSS Raw Data in Vehicular Networks

The evolution and integration of communication networks and positioning technologies are evolving at a fast pace in the framework of vehicular systems. The mutual dependency of such two capabilities can enable several new cooperative paradigms, whose adoption is however slowed down by the lack of suitable open protocols, especially related to the positioning and navigation domain. In light of this, the paper introduces a novel vehicular message type, namely the Cooperative Enhancement Message (CEM), and an associated open protocol to enable the sharing of Global Navigation Satellite Systems (GNSS) raw measurements among connected vehicles. The proposed CEM aims at extending existent approaches such as Cooperative Awareness Messages (CAM) and Collective Perception Messages (CPM) by complementing their paradigms with a cooperative enhancement of the localization accuracy, precision, and integrity proposed by state-of-the-art solutions. Besides the definition of CEMs and a related protocol, a validation of the approach is proposed through a novel simulation framework. A preliminary analysis of the network performance is presented in the case where CEM and CAM transmissions coexist and are concurrently used to support cooperative vehicle applications

The LuGRE project: a scientific opportunity to study GNSS signals at the Moon

The Lunar GNSS Receiver Experiment (LuGRE) is a joint NASA-Italian Space Agency (ASI) payload on the Firefly Blue Ghost Mission 1 with the goal to demonstrate GNSS-based positioning, navigation, and timing at the Moon. When launched, LuGRE will collect GPS and Galileo measurements in transit between Earth and the Moon, in lunar orbit, and on the lunar surface, and will conduct onboard and ground-based navigation experiments using the collected data. These investigations will be based on the observation of the data collected by a custom development performed by the company Qascom, based on the Qascom QN400-Space GNSS receiver. The receiver is able to provide, PVT solutions, the GNSS raw observables obtained by the real time operation, as well as snapshots of IF digital samples collected by the RF front-end at frequencies L1/E1 and L5/E5. These data will be the input for the different science investigations, that require then the development of proper analysis tools that will be the core of the ground segment during the mission. The current work done by the science team of NASA and ASI, which is supported by a research team at Politecnico di Torino, is planning the data acquisitions during the time windows dedicated to the LuGRE payload in the checkout, transit and surface mission phases

Antenna Deployment for a Pathfinder Lunar Radio Observatory

A first step in the development of a large radio observatory on the moon for cosmological or other astrophysical and planetary goals is to deploy a few antennas as a pathfinder mission. In this presentation, we describe a mechanism being developed to deploy such antennas from a small craft, such as a Google Lunar X-prize lander. The antenna concept is to deposit antennas and leads on a polyimide film, such as Kapton, and to unroll the film on the lunar surface. The deployment technique utilized is to launch an anchor which pulls a double line from a reel at the spacecraft. Subsequently, the anchor is set by catching on the surface or collecting sufficient regolith. A motor then pulls in one end of the line, pulling the film off of its roller onto the lunar surface. Detection of a low frequency cutoff of the galactic radio background or of solar radio bursts by such a system would determine the maximum lunar ionospheric density at the time of measurement. The current design and testing, including videos of the deployment, will be presented. These activities are funded in part by the NASA Lunar Science Institute as an activity of the Lunar University Network for Astrophysical Research (LUNAR) consortium. Part of this research was carried out at the Jet Propulsion Laboratory, California Institute of Technology, under a contract with the National Aeronautics and Space Administration

A simple cytofluorimetric score may optimize testing for biallelic CEBPA mutations in patients with acute myeloid leukemia

Acute myeloid leukemia with biallelic mutation of CEBPA (CEBPA-dm AML) is a distinct good prognosis entity recognized by WHO 2016 classification. However, testing for CEBPA mutation is challenging, due to the intrinsic characteristics of the mutation itself. Indeed, molecular analysis cannot be performed with NGS technique and requires Sanger sequencing. The association of recurrent mutations or translocations with specific immunophenotypic patterns has been already reported in other AML subtypes. The aim of this study was the development of a specific cytofluorimetric score (CEBPA-dm score), in order to distinguish patients who are unlikely to harbor the mutation. To this end, the correlation of CEBPA-dm score with the presence of the mutation was analyzed in 50 consecutive AML patients with normal karyotype and without NPM1 mutation (that is mutually exclusive with CEBPA mutation). One point each was assigned for expression of HLA DR, CD7, CD13, CD15, CD33, CD34 and one point for lack of expression of CD14. OS was not influenced by sex, age and CEBPA-dm score. Multivariate OS analysis showed that CEBPA-dm (p < 0.02) and FLT3-ITD (p < 0.01) were the strongest independent predictors of OS. With a high negative predictive value (100%), CEBPA-dm score < 6 was able to identify patients who are unlikely to have the mutation. Therefore, the application of this simple score might optimize the use of expensive and time-consuming diagnostic and prognostic assessment in the baseline work up of AML patients

Fludarabine, high-dose cytarabine and idarubicin-based induction may overcome the negative prognostic impact of flt3-itd in npm1 mutated aml, irrespectively of flt3-itd allelic Burden

The mutations of NPM1 and FLT3-ITD represent the most frequent genetic aberration in acute myeloid leukemia. Indeed, the presence of an NPM1 mutation reduces the negative prognostic impact of FLT3-ITD in patients treated with conventional \u201c3+7\u201d induction. However, little information is available on their prognostic role with intensified regimens. Here, we investigated the efficacy of a fludarabine, high-dose cytarabine and idarubicin induction (FLAI) in 149 consecutive fit AML patients (median age 52) carrying the NPM1 and/or FLT3-ITD mutation, treated from 2008 to 2018. One-hundred-and-twenty-nine patients achieved CR (86.6%). After a median follow up of 68 months, 3-year overall survival was 58.6%. Multivariate analysis disclosed that both NPM1mut (p < 0.05) and ELN 2017 risk score (p < 0.05) were significant predictors of survival. NPM1-mutated patients had a favorable outcome, with no significant differences between patients with or without concomitant FLT3-ITD (p = 0.372), irrespective of FLT3-ITD allelic burden. Moreover, in landmark analysis, performing allogeneic transplantation (HSCT) in first CR proved to be beneficial only in ELN 2017 high-risk patients. Our data indicate that FLAI exerts a strong anti-leukemic effect in younger AML patients with NPM1mut and question the role of HSCT in 1st CR in NPM1mut patients with concomitant FLT3-ITD

Fludarabine, high-dose cytarabine and idarubicin-based induction may overcome the negative prognostic impact of flt3-itd in npm1 mutated aml, irrespectively of flt3-itd allelic Burden

The mutations of NPM1 and FLT3-ITD represent the most frequent genetic aberration in acute myeloid leukemia. Indeed, the presence of an NPM1 mutation reduces the negative prognostic impact of FLT3-ITD in patients treated with conventional “3+7” induction. However, little information is available on their prognostic role with intensified regimens. Here, we investigated the efficacy of a fludarabine, high-dose cytarabine and idarubicin induction (FLAI) in 149 consecutive fit AML patients (median age 52) carrying the NPM1 and/or FLT3-ITD mutation, treated from 2008 to 2018. One-hundred-and-twenty-nine patients achieved CR (86.6%). After a median follow up of 68 months, 3-year overall survival was 58.6%. Multivariate analysis disclosed that both NPM1mut (p &lt; 0.05) and ELN 2017 risk score (p &lt; 0.05) were significant predictors of survival. NPM1-mutated patients had a favorable outcome, with no significant differences between patients with or without concomitant FLT3-ITD (p = 0.372), irrespective of FLT3-ITD allelic burden. Moreover, in landmark analysis, performing allogeneic transplantation (HSCT) in first CR proved to be beneficial only in ELN 2017 high-risk patients. Our data indicate that FLAI exerts a strong anti-leukemic effect in younger AML patients with NPM1mut and question the role of HSCT in 1st CR in NPM1mut patients with concomitant FLT3-ITD

CPX-351 treatment in secondary acute myeloblastic leukemia is effective and improves the feasibility of allogeneic stem cell transplantation: results of the Italian compassionate use program

Secondary acute myeloid leukemia (sAML) poorly responds to conventional treatments and allogeneic stem cell transplantation (HSCT). We evaluated toxicity and efficacy of CPX-351 in 71 elderly patients (median age 66 years) with sAML enrolled in the Italian Named (Compassionate) Use Program. Sixty days treatment-related mortality was 7% (5/71). The response rate at the end of treatment was: CR/CRi in 50/71 patients (70.4%), PR in 6/71 (8.5%), and NR in 10/71 (19.7%). After a median follow-up of 11 months relapse was observed in 10/50 patients (20%) and 12 months cumulative incidence of relapse (CIR) was 23.6%. Median duration of response was not reached. In competing risk analysis, CIR was reduced when HSCT was performed in first CR (12 months CIR of 5% and 37.4%, respectively, for patients receiving (=20) or not (=30) HSCT, p = 0.012). Twelve-months OS was 68.6% (median not reached). In landmark analysis, HSCT in CR1 was the only significant predictor of longer survival (12 months OS of 100 and 70.5%, for patients undergoing or not HSCT in CR1, respectively, p = 0.011). In conclusion, we extend to a real-life setting, the notion that CPX is an effective regimen for high risk AML patients and may improve the results of HSCT

Crenças e práticas educativas de mães de crianças com desenvolvimento atípico

Resumo O desenvolvimento humano atípico interfere no processo de aprendizado da criança que o apresenta, sendo que os pais têm importante papel no sentido de estimular o desenvolvimento dos filhos. Porém, o envolvimento paterno sofre influência das crenças que os pais têm sobre o desenvolvimento dos filhos. Para avaliá-las, Suizzo (2002) construiu a Escala de Crenças Parentais e Práticas de Cuidado (E-CPPC). Assim, na presente pesquisa foi realizada uma pesquisa descritiva e transversal, utilizando o E-CPPC com 75 mães de crianças com diagnóstico de deficiência intelectual, das quais 41 sem fenótipo (grupo que abrangeu, dentre outros, crianças com Transtorno do Espectro Autista), cuja deficiência intelectual foi percebida nos primeiros anos de vida, e 34 mães de crianças com Síndrome de Down, identificada quando do nascimento. Das crianças com Síndrome de Down, 94,11% frequentavam escola especial e este percentual baixou para 80,48% nas crianças sem fenótipo. As mães dos dois agrupamentos apontaram em primeiro lugar a dimensão Apresentação Apropriada do bebê, envolvendo aqui a valorização de cuidados básicos, vindo a seguir: Estimulação; Responsividade/vínculo; Disciplina. Na análise de pares de dimensões do E-CPPC foi percebido que somente no par de dimensões Apresentação-Responsividade/vínculo houve diferença entre os grupos, sendo positiva e com significância estatística nas crianças com Síndrome de Down e não apresentando relação significativa no outro grupo. Poder contar com rede de apoio o quanto antes surge como sugestão importante aos dois grupos